Leucine-Rich Repeats And Immunoglobulin-Like Domains Protein 2 (LRIG2) Antibody

Este producto es parte de LRIG - leucine rich repeats and immunoglobulin like domains
Product Graph
357.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Leucine-Rich Repeats And Immunoglobulin-Like Domains Protein 2 (LRIG2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx037223
tested applications
ELISA, WB, IHC

Description

Rabbit Polyclonal against the LRIG2 protein.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Leucine-Rich Repeats And Immunoglobulin-Like Domains Protein 2 (LRIG2)
Host
Rabbit
Reactivity
Human
Recommended Dilution
ELISA: 1/20000 - 1/80000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by antigen affinity column chromatography.
Size 1
100 µg
Size 2
1 mg
Form
Lyophilized
Tested Applications
ELISA, WB, IHC
Buffer
Prior to lyophilization: 1% BSA and 0.02% NaN3.
Availability
Shipped within 7-15 working days.
Storage
Store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
LIG2,UFS2,LIG-2
Background
Antibody anti-LRIG2
Status
RUO
Note
Concentration: Lyophilized form: Not applicable.  After reconstitution: 1 mg/ml. - 

Descripción

LRIG2 is a close homolog of LRIG1, sharing structural features such as LRR domains and Ig-like domains that facilitate extracellular protein interactions. LRIG2 is primarily expressed in neural tissues and the urogenital tract, suggesting roles in neural development, tissue repair, and cell signaling. Unlike LRIG1, LRIG2 has been identified as a positive regulator of receptor tyrosine kinases, enhancing growth factor signaling.  LRIG2 is implicated in glioblastomas and other aggressive cancers, where it promotes cell proliferation, migration, and survival. In non-cancer contexts, LRIG2 contributes to maintaining tissue integrity and regulating neural processes. Mutations in LRIG2 are associated with developmental disorders, including urofacial syndrome, which affects facial and urinary function. Its opposing regulatory roles compared to LRIG1 underline the diverse functionality of the LRIG family.

Related Products

abx037223

Leucine-Rich Repeats And Immunoglobulin-Like Domains Protein 2 (LRIG2) Antibody

Rabbit Polyclonal against the LRIG2 protein.

Ver Producto
abx343785

Leucine-rich repeats and immunoglobulin-like domains protein 2 (LRIG2) Antibody

Leucine-rich repeats and immunoglobulin-like domains protein 2 (LRIG2) Antibody is a Rabbit Polyclonal antibody for the detection of Human LRIG2.

Ver Producto
abx343786

Leucine-rich repeats and immunoglobulin-like domains protein 2 (LRIG2) Antibody (HRP)

Leucine-rich repeats and immunoglobulin-like domains protein 2 (LRIG2) Antibody (HRP) is a Rabbit Polyclonal antibody conjugated to HRP for the detection of Human LRIG2.

Ver Producto